AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Connecticut

HB06146

An Act Concerning The Psychedelic-assisted Therapy Pilot Program.

Status

Did not pass; died when the session ended

2023 Session

IntroducedJan 18, 2023 (done)
PassedDid not happen (skipped)
SignedDid not happen (skipped)
Law in effectDid not happen (skipped)

Sponsor: Michelle Cook (Democrat)
Type: Appropriations / Administrative
Substances: Psilocybin

Official text

Summary (from PoliPsy)

To fund the psychedelic-assisted therapy pilot program.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: cga.ct.gov

Legislative history

February 8, 2023
Change of Reference, Senate to Committee on Appropriations
January 18, 2023
Referred
January 18, 2023
Introduced

Loading bill…